Similar articles for PMID: 23024587

Year	Number of Results
1998	1
2002	1
2003	1
2004	2
2005	7
2006	5
2007	2
2008	2
2009	7
2010	5
2011	7
2012	9
2013	6
2014	7
2015	8
2016	2
2017	4
2018	9
2019	3
2020	8
2021	2
2024	0

1

Meningococcal vaccines in Canada: An update.

Salvadori M, Bortolussi R. Salvadori M, et al. Paediatr Child Health. 2011 Oct;16(8):485-6. doi: 10.1093/pch/16.8.485. Paediatr Child Health. 2011. PMID: 23024587 Free PMC article.

2

Vaccinating adolescents against meningococcal disease in Canada: a cost-effectiveness analysis.

De Wals P, Coudeville L, Trottier P, Chevat C, Erickson LJ, Nguyen VH. De Wals P, et al. Vaccine. 2007 Jul 20;25(29):5433-40. doi: 10.1016/j.vaccine.2007.04.071. Epub 2007 May 15. Vaccine. 2007. PMID: 17560695

3

Update on invasive meningococcal vaccination for Canadian children and youth.

Robinson JL. Robinson JL. Paediatr Child Health. 2018 Feb;23(1):e1-e4. doi: 10.1093/pch/pxx162. Epub 2018 Feb 15. Paediatr Child Health. 2018. PMID: 29479282 Free PMC article.

4

Cost-effectiveness of alternate strategies for childhood immunization against meningococcal disease with monovalent and quadrivalent conjugate vaccines in Canada.

Delea TE, Weycker D, Atwood M, Neame D, Alvarez FP, Forget E, Langley JM, Chit A. Delea TE, et al. PLoS One. 2017 May 4;12(5):e0175721. doi: 10.1371/journal.pone.0175721. eCollection 2017. PLoS One. 2017. PMID: 28472165 Free PMC article.

5

A new meningococcal conjugate vaccine: What should physicians know and do?

Bortolussi R, Salvadori M. Bortolussi R, et al. Paediatr Child Health. 2009 Oct;14(8):515-20. doi: 10.1093/pch/14.8.515. Paediatr Child Health. 2009. PMID: 20885803 Free PMC article.

6

Comparative trial of the safety and immunogenicity of quadrivalent (A, C, Y, W-135) meningococcal polysaccharide-diphtheria conjugate vaccine versus quadrivalent polysaccharide vaccine in two- to ten-year-old children.

Pichichero M, Casey J, Blatter M, Rothstein E, Ryall R, Bybel M, Gilmet G, Papa T. Pichichero M, et al. Pediatr Infect Dis J. 2005 Jan;24(1):57-62. doi: 10.1097/01.inf.0000148928.10057.86. Pediatr Infect Dis J. 2005. PMID: 15665711 Clinical Trial.

7

Meningococcal conjugate vaccines policy update: booster dose recommendations.

Committee on Infectious Diseases. Committee on Infectious Diseases. Pediatrics. 2011 Dec;128(6):1213-8. doi: 10.1542/peds.2011-2380. Epub 2011 Nov 28. Pediatrics. 2011. PMID: 22123893

8

Primary immunization of meningococcal meningitis vaccine among children in Hangzhou, China, 2008-2017.

Che X, Liu Y, Wang J, Xu Y, Zhang X, Gu W, Jiang W, Du J, Zhang X. Che X, et al. Hum Vaccin Immunother. 2021 Apr 3;17(4):1239-1243. doi: 10.1080/21645515.2020.1809264. Epub 2020 Sep 22. Hum Vaccin Immunother. 2021. PMID: 32961071 Free PMC article.

9

Safety, immunogenicity, and immune memory of a novel meningococcal (groups A, C, Y, and W-135) polysaccharide diphtheria toxoid conjugate vaccine (MCV-4) in healthy adolescents.

Keyserling H, Papa T, Koranyi K, Ryall R, Bassily E, Bybel MJ, Sullivan K, Gilmet G, Reinhardt A. Keyserling H, et al. Arch Pediatr Adolesc Med. 2005 Oct;159(10):907-13. doi: 10.1001/archpedi.159.10.907. Arch Pediatr Adolesc Med. 2005. PMID: 16203934 Clinical Trial.

10

Licensure of a meningococcal conjugate vaccine for children aged 2 through 10 years and updated booster dose guidance for adolescents and other persons at increased risk for meningococcal disease--Advisory Committee on Immunization Practices (ACIP), 2011.

Centers for Disease Control and Prevention (CDC). Centers for Disease Control and Prevention (CDC). MMWR Morb Mortal Wkly Rep. 2011 Aug 5;60(30):1018-9. MMWR Morb Mortal Wkly Rep. 2011. PMID: 21814165 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

88 results

Results by year